Lepsy

Lepsy

levetiracetam

Manufacturer:

Yarindo Farmatama
Concise Prescribing Info
Contents
Levetiracetam
Indications/Uses
Adjunctive therapy for partial seizure w/ or w/o secondary generalization in epileptic patients.
Dosage/Direction for Use
Adult & adolescents >16 yr Initially 500 mg twice daily, can be increased up to 1,500 mg twice daily. Dose adjustment can be done by adding or subtracting 500 mg twice daily every 2-4 wk. Elderly w/ impaired kidney function CrCl >80 mL/min 500-1,500 mg twice daily, CrCl 50-79 mL/min 500-1,000 mg twice daily, CrCl 30-49 mL/min 250-750 mg twice daily, CrCl <30 mL/min 250-500 mg twice daily. Terminal stage of CKD undergoing hemodialysis 500-1,000 mg twice daily.
Administration
May be taken with or without food: Swallow whole w/ water.
Contraindications
Hypersensitivity to levetiracetam or other pyrrolidone derivatives or other additives.
Special Precautions
Treatment w/drawal should be done gradually. Avoid driving or operating machine while consuming drug. Do not use in pregnancy & lactation unless mandatory.
Adverse Reactions
Asthenia, drowsiness, amnesia, ataxia, convulsion, dizziness, headache, tremor, depression, emotion liability, hostility, insomnia, nervousness, abnormal behavior, aggression, anger, anxiety, confusion, hallucination, irritability, psychosis, diarrhea, dyspepsia, nausea, anorexia, vertigo, skin rash, leucopenia, neutropenia, thrombocytopenia, pancytopenia.
MIMS Class
Anticonvulsants
ATC Classification
N03AX14 - levetiracetam ; Belongs to the class of other antiepileptics.
Presentation/Packing
Form
Lepsy tab 500 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in